0000899243-21-028516.txt : 20210715
0000899243-21-028516.hdr.sgml : 20210715
20210715181617
ACCESSION NUMBER: 0000899243-21-028516
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210715
FILED AS OF DATE: 20210715
DATE AS OF CHANGE: 20210715
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MacBeath Gavin
CENTRAL INDEX KEY: 0001738082
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40603
FILM NUMBER: 211093654
MAIL ADDRESS:
STREET 1: C/O ABPRO CORPORATION
STREET 2: 65 CUMMINGS PARK DRIVE
CITY: WOBURN
STATE: MA
ZIP: 01801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TScan Therapeutics, Inc.
CENTRAL INDEX KEY: 0001783328
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 825282075
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 857-399-9500
MAIL ADDRESS:
STREET 1: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2021-07-15
0
0001783328
TScan Therapeutics, Inc.
TCRX
0001738082
MacBeath Gavin
C/O TSCAN THERAPEUTICS, INC.
830 WINTER STREET
WALTHAM
MA
02451
0
1
0
0
Chief Scientific Officer
Voting Common Stock
44767
D
Employee Stock Option (right to buy)
1.97
2029-01-23
Voting Common Stock
35302
D
Employee Stock Option (right to buy)
2.46
2029-12-17
Voting Common Stock
52575
D
Employee Stock Option (right to buy)
5.82
2031-01-26
Voting Common Stock
166577
D
The shares originally subject to this option vested over 4 years of service following December 3, 2018, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter. In addition, all of the shares subject to this option shall vest and become fully exercisable upon a Change of Control (as defined in the option agreement).
The shares originally subject to this option vested over 4 years of service following December 5, 2019, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter.
The shares subject to this option vest over 4 years of service following January 25, 2021, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter.
/s/ Gavin MacBeath
2021-07-15